Cardiology (all articles)
Meta-analysis: Association of SGLT2 inhibitors with cardiovascular and kidney outcomes in patients with Type 2 diabetes
8 Oct, 2020 | 08:57h | UTC
Expert analysis: Very low carbohydrate and ketogenic diets and cardiometabolic risk
8 Oct, 2020 | 08:58h | UTCVery Low Carbohydrate and Ketogenic Diets and Cardiometabolic Risk – American College of Cardiology
Long-term health consequences of COVID-19
6 Oct, 2020 | 00:58h | UTCLong-term Health Consequences of COVID-19 – JAMA
Commentary on Twitter
Persistent post-COVID symptoms could be the from direct tissue invasion by the virus, profound inflammation & cytokine storm, related immune system damage, hypercoagulable state, or some combination https://t.co/G8tI9U3TaL @CarlosdelRio7 lfcollins_md @PreetiNMalani
— JAMA (@JAMA_current) October 5, 2020
Cohort study: In-hospital cardiac arrest in critically ill patients with Covid-19
2 Oct, 2020 | 09:24h | UTCCommentary: Cardiac arrest, poor survival rates common in sickest patients with COVID-19 – University of Michigan
Related Study: Clinical Outcomes of In-Hospital Cardiac Arrest in COVID-19 – JAMA Internal Medicine
Commentaries on Twitter
Cardiac arrest with severe #COVID19, in-hospital:
relatively common, very poor outcome, especially w/ ⬆️age
Two series:
701 patients (14%)https://t.co/Pu0V15lemL @bmj_latest @salimhayek @umichmedicine @MHealthLab
60 patients (5%)https://t.co/Exwk68VXgg @JAMAInternalMed pic.twitter.com/9cwS0HlNxz— Eric Topol (@EricTopol) October 2, 2020
Cardiac arrest is common in critically ill patients with #COVID19 and is associated with poor survival, particularly among patients aged 80 or older, finds new research @salimhayek
https://t.co/O2Z2K3TAeT— The BMJ (@bmj_latest) October 1, 2020
Drug-related orthostatic hypotension: Beyond anti-hypertensive medications
2 Oct, 2020 | 09:13h | UTCDrug-Related Orthostatic Hypotension: Beyond Anti-Hypertensive Medications – Drugs & Aging
Commentary on Twitter
Drug-Related Orthostatic Hypotension: Beyond Anti-Hypertensive Medications. An open access review … https://t.co/YB0KiEiAtF pic.twitter.com/YzfsmQmtbZ
— Rohan Elliott (@elliott_rohan) September 30, 2020
Viewpoint: COVID-19 and heart failure with preserved ejection fraction
1 Oct, 2020 | 09:06h | UTCCOVID-19 and Heart Failure With Preserved Ejection Fraction – JAMA
AHA Scientific Statement: Cardiorenal protection with the newer antidiabetic agents in patients with diabetes and chronic kidney disease
29 Sep, 2020 | 10:00h | UTCNews Release: Newer Type 2 diabetes medications have heart and kidney disease benefits, too – AHA Newsroom
JAMA Network Series: Medical Specialties and the COVID-19 Pandemic
24 Sep, 2020 | 09:45h | UTCEditorial: The COVID-19 Pandemic and the JAMA Network
See articles:
- Cardiology and COVID-19
- Dermatology and COVID-19
- Internal Medicine and COVID-19
- Nephrology and COVID-19
- Neurology and COVID-19
- Oncology and COVID-19
- Ophthalmology and COVID-19
- Otolaryngology–Head and Neck Surgery and COVID-19
- Pediatrics and COVID-19
- Psychiatry and COVID-19
- Surgery and COVID-19
- JAMA Network Open and COVID-19
- JAMA Health Forum and COVID-19
COVID-19 can affect the heart
24 Sep, 2020 | 09:30h | UTCCOVID-19 can affect the heart – Science
Commentary on Twitter
"These complications, which at times are the only features of #COVID19 clinical presentation, have occurred even in cases with mild symptoms and in people who did not experience any symptoms" https://t.co/q42cY3ujV4
a ?to explain 1/— Eric Topol (@EricTopol) September 24, 2020
Meta-analysis: Central fatness and risk of all-cause mortality
24 Sep, 2020 | 09:19h | UTC
Commentary on Twitter
Central fatness is associated with a higher risk of early death from any cause, regardless of overall body fat, whereas larger hips and thighs are associated with a lower risk, finds this studyhttps://t.co/7NucNY7zFt
— The BMJ (@bmj_latest) September 23, 2020
Diagnostic test interpretation: Coronary computed tomography angiography
24 Sep, 2020 | 09:14h | UTCCoronary Computed Tomography Angiography – JAMA (free for a limited period)
Cardiac arrhythmias in critically ill patients with COVID-19: A brief review
22 Sep, 2020 | 09:59h | UTC
The core lesson of the COVID-19 heart debate
22 Sep, 2020 | 10:00h | UTCThe Core Lesson of the COVID-19 Heart Debate – The Atlantic
Commentary on Twitter
The Atlantic does a fantastic job in presenting balance. I'm happy I was able to contribute to this discussion about COVID and the heart in a small way. This is definitely worth the time to read #Covid #heart. https://t.co/gjtzZ7iRiy
— Paul Checchia (@ChecchiaPaul) September 21, 2020
Guideline: Management of dyslipidemia for cardiovascular disease risk reduction
22 Sep, 2020 | 09:33h | UTCSummary: VA/DoD Guidelines on Dyslipidemia Recommend Against Frequent LDL Testing – NEJM Journal Watch
Commentary on Twitter
New VA/DoD dyslipidemia guidelines in @AnnalsofIM. Highlights: treat to target statin dose not LDL levels, say no to PCSK9 inh for primary prevention, Mediterranean diet is awesome, don’t check lipid levels more frequently than every 10 years. #MedTwitter https://t.co/aNX2xWitAG
— Aaron Tallant (@ATallantMD) September 22, 2020
Editorial: Two remedies for inappropriate percutaneous coronary intervention—closing the gap between evidence and practice
22 Sep, 2020 | 09:28h | UTCEditorial: Two Remedies for Inappropriate Percutaneous Coronary Intervention—Closing the Gap Between Evidence and Practice (free for a limited period)
Original Studies: Potential Association of the ISCHEMIA Trial With the Appropriate Use Criteria Ratings for Percutaneous Coronary Intervention in Stable Ischemic Heart Disease – JAMA Internal Medicine (free for a limited period) AND US False Claims Act Investigations of Unnecessary Percutaneous Coronary Interventions – JAMA Internal Medicine (free for a limited period)
Clinical update: Hormonal contraception in women with hypertension
22 Sep, 2020 | 09:32h | UTCHormonal Contraception in Women With Hypertension – JAMA (free for a limited period)
Commentary on Twitter
Ethinyl estradiol, the synthetic estrogen in combined hormonal contraceptives, has vascular and hepatic effects that may increase vascular resistance, pro-thrombotic & -inflammatory effects, & dyslipidemia, all of which contribute to CVD https://t.co/UiLKXJ9b0i @cshufeltMD
— JAMA (@JAMA_current) September 21, 2020
A comprehensive update on aspirin management during noncardiac surgery
22 Sep, 2020 | 09:24h | UTCA Comprehensive Update on Aspirin Management During Noncardiac Surgery – Anesthesia & Analgesia
ESC Position Paper: Integration of a palliative approach into heart failure care
18 Sep, 2020 | 09:24h | UTC
Commentary on Twitter
Palliative care should be part of every #heartfailure management programme. Read about how you can discuss and implement it in #EJHF https://t.co/lpR3Jb1I9p@MarcoMetra @HFA_President @kevin_damman pic.twitter.com/tA9nCMHiyS
— European Society of Cardiology Journals (@ESC_Journals) September 17, 2020
Randomized trial: Opportunistic screening vs. usual care for detection of atrial fibrillation in primary care
17 Sep, 2020 | 09:21h | UTC
Commentary on Twitter
Opportunistic screening for atrial fibrillation in primary care patients, aged 65 and over, did not increase the detection rate of atrial fibrillation, finds this cluster randomised controlled trialhttps://t.co/PnjTZO9IKC
— The BMJ (@bmj_latest) September 16, 2020
Lifelong aspirin for all in the secondary prevention of chronic coronary syndrome: Still sacrosanct or is reappraisal warranted?
17 Sep, 2020 | 09:19h | UTCLifelong Aspirin for All in the Secondary Prevention of Chronic Coronary Syndrome: Still Sacrosanct or is Reappraisal Warranted? – Circulation (free for a limited period)
Multisystem effects of COVID-19: A concise review for practitioners
16 Sep, 2020 | 09:14h | UTCMultisystem effects of COVID-19: A concise review for practitioners – Postgraduate Medicine
Open letter calls on cardiovascular societies to discourage cardiac magnetic resonance after mild COVID-19
16 Sep, 2020 | 09:09h | UTCOpen Letter Calls on CV Societies to Discourage CMR After Mild COVID-19 – TCTMD
AHA Scientific Statement: Drug-induced arrhythmias
16 Sep, 2020 | 08:50h | UTCDrug-Induced Arrhythmias: A Scientific Statement From the American Heart Association – Circulation
Commentary: Drug Proarrhythmia
Top Things to Know: Drug-Induced Arrhythmias
News Release: Identifying, preventing and managing heart rhythm side effects of medicines
Cohort study: Intra-arrest transport vs. continued on-scene resuscitation in patients with out-of-hospital cardiac arrest
16 Sep, 2020 | 08:48h | UTCAssociation of Intra-arrest Transport vs Continued On-Scene Resuscitation With Survival to Hospital Discharge Among Patients With Out-of-Hospital Cardiac Arrest – JAMA (free for a limited period)
Editorial: Challenging the “Scoop and Run” Model for Management of Out-of-Hospital Cardiac Arrest (free for a limited period)
Commentary: For Cardiac Arrest, Too-Hasty Transport Gets in the Way of Good CPR – MedPage Today (free registration required)
Commentary on Twitter
So "Stay and Play" beats "Scoop and Run", at least for cardiac arrest. Intra-arrest Transport vs Continued On-Scene Resuscitation and Survival in Patients With Out-of-Hospital… https://t.co/cjazp4jn1e via @JAMA_current part of @JAMANetwork
— Matthew Martin (@docmartin22) September 16, 2020
Cardiovascular magnetic resonance findings in competitive athletes recovering from COVID-19
14 Sep, 2020 | 01:14h | UTCCommentary: Athletes Have Telltale CMR Markers of Damage Post-COVID-19, but Clinical Significance Unclear – TCTMD
Commentary on Twitter (thread)
Key points about the latest athlete cardiac MRI paper. https://t.co/mtsjapZjMQ
— Anish Koka (@anish_koka) September 11, 2020